Medizalbu is a premium Human Normal Albumin Injection 20% Solution for Infusion developed to support patients who require plasma volume expansion and albumin replacement therapy. Human albumin is a naturally occurring plasma protein that plays an essential role in maintaining blood volume, oncotic pressure, and the transport of hormones, enzymes, drugs, and other substances throughout the body. Medizalbu is intended for intravenous administration under the supervision of qualified healthcare professionals.
Human Normal Albumin Injection is a sterile, non-pyrogenic solution prepared from human plasma. It is commonly used in hospitals, intensive care units (ICUs), emergency departments, and surgical settings to restore circulating blood volume and treat patients with low albumin levels (hypoalbuminemia). Albumin therapy helps maintain fluid balance within blood vessels, improving circulation and supporting recovery in critically ill patients.
Product Name: Medizalbu
Generic Name: Human Normal Albumin Injection
Strength: Human Albumin 20% Solution for Infusion
Dosage Form: Sterile Intravenous Infusion
Pack Size: 100 ml
Administration: Intravenous infusion under medical supervision
Storage: Store at 2°C–8°C. Do not freeze.
Medizalbu is prescribed for various critical medical conditions, including:
Hypoalbuminemia (low blood albumin levels)
Hypovolemia (reduced blood volume)
Severe burns
Hemorrhagic shock
Liver cirrhosis and related complications
Nephrotic syndrome
Major surgeries
Trauma management
Critical care and ICU patients
Plasma volume replacement therapy
Restores and maintains plasma volume
Helps improve blood circulation
Maintains oncotic pressure
Supports fluid balance in critically ill patients
Assists in the management of hypoalbuminemia
Used extensively in emergency and intensive care medicine
Manufactured under stringent quality standards for safety and reliability
Albumin is the major protein present in human plasma. It helps retain fluid within blood vessels, preventing leakage into surrounding tissues. During conditions such as severe burns, shock, liver disease, or major surgery, albumin levels may decrease significantly. Medizalbu replenishes albumin levels, restores plasma volume, improves circulation, and supports overall patient stabilization.
The dosage of Human Normal Albumin Injection depends on:
Patient body weight
Clinical condition
Degree of albumin deficiency
Blood volume status
Physician's assessment
Medizalbu should only be administered by qualified healthcare professionals through intravenous infusion. Self-administration is not recommended.
Before administering Medizalbu, healthcare professionals should evaluate:
History of allergy to albumin products
Cardiac conditions
Kidney disorders
Liver disease
Fluid overload conditions
Electrolyte imbalance
Continuous monitoring during infusion is recommended.
Like all medicines, Human Normal Albumin Injection may cause side effects in some patients, including:
Fever
Chills
Headache
Nausea
Skin rash
Injection site reactions
Rare allergic reactions
Patients experiencing severe reactions should receive immediate medical attention.
Medizalbu is designed to meet the needs of hospitals, healthcare institutions, distributors, and pharmaceutical partners by offering:
Reliable hospital supply
Stringent quality standards
Sterile manufacturing processes
Consistent product availability
Bulk supply support
Third-party manufacturing opportunities
Distribution across India and international markets
Human Normal Albumin Injection is widely used in:
Intensive Care Units (ICUs)
Emergency departments
Trauma centers
Liver disease management
Burn units
Surgical recovery
Nephrology departments
Critical care hospitals
Healthcare providers choose Medizalbu because of its quality, consistency, and reliable therapeutic performance. It supports plasma volume expansion, improves patient stabilization, and helps manage several life-threatening conditions requiring albumin replacement therapy.
Human Normal Albumin Injection, marketed under the product name Medizalbu, is an essential plasma-derived therapy for treating hypoalbuminemia, hypovolemia, liver disease, severe burns, shock, and other critical care conditions. With its high-quality formulation, dependable supply, and commitment to patient safety, Medizalbu is an excellent choice for hospitals, distributors, and healthcare providers seeking a reliable Human Albumin 20% Solution for Infusion.
Keywords: Human Normal Albumin Injection, Medizalbu, Human Albumin Injection 20%, Human Albumin Solution for Infusion, Human Serum Albumin Injection, Albumin Infusion, Human Albumin Uses, Human Albumin Dosage, Human Albumin Manufacturer, Human Albumin Supplier, Human Albumin Exporter, Human Albumin Injection India.